1

NEWSLETTER Volume 13 Issue 1 | Spring/Summer Edition | 2019

Congratulations to the Roseman University Pharm. D. Graduating Class of 2019

Courtney R. Acton Victoreea S. Harris Calida B. Morris Samahn Soleimanian Alain J.M. Agabadje Eric D. Hartung Rachael W. Mukuha Ngwa A. Standly Danijela Andric Stacy A. Henry Justine H. M. Nguyen Hyunsuk Sung Thuy T. Antolin Alba K. Hernandez Gaona Kathy Q. X. Nguyen Lacie K. Taketa Russel F. Arceo Luke N. Hess Khoa A. Nguyen Chanyis N. D. Taylor Yana Avnilova Vivian W. Y. Ho Kieu Loan T. Nguyen Natalie T. Than Hedeel H. Bahnam Chau K. Hua Lisa Nguyen Yousef Toma Mikiyas M. Bati Yip Huynh Loc-Jeffrey T. Nguyen Angela D. Torosian Florence N. Besong-Asah Amara O. Igwe Rachel Nguyen Jackie Tran Alexander R. B. Boesche Ashkan Isakharian Stephanie R. Nguyen Khuong A. Tran Tessa L. Bui Alec Z. Jacinto Tammy T. Nguyen Vincent P. Tran Christen A. Cain Melissa A. Janos Thu A. T. Nguyen Vy N. Tran Marina K. Canelon Shawn E. Jensen Tina M. Nguyen Huong H. Trieu Andrew P. Carapucci Ashley M. L. Juan John P. A. Obena Alleia R. Untalasco Eddy J. Chan Haddish M. Kahsay Chuka O. C. Okafor Taylor R. Vega Karen Chan Kurt A. Kaleb Estelle F. M. Olson Hoangmy D. Vo Victoria Chan (Te) Matthew H. Kikuchi Sarah Mae M. Pascual Vuong V. Vo Marky E. Corrington Sharon B. Kim Jaykumar R. Patel Jacoby J. Wayne-Thompson Selena M. K. Crivello Manish Kumar Sejalben N. Patel Helen G. Woldemariam Brent J. Czerniak Christine G. Ladaga Natalie Peng Xiu Min Wu-Ma Bruce T. Dang Erin Grace V. Lam Clara Anh Thu Vo Pham Seema V. Yadav Vy H.K. Dang Michael V. Lam Dalena D. Pham Farbod Youshei Maribel Diaz Jaden L. Le Kim-Ngan C. Pham Kenneth Dinh Lysa C. Le Lynni N. Pham Tommy H. Dinh Phoung Nhi T. Le Teresa A. V. Pham Theresa T. V. Do Nathan S. H. Lee Twain T. Pham William T. Eckert II Stacey Lee Phillip H. D. Phan Jennifer Eliav Ivy K. Y. Leung Vanessa V. T. T. Phi Georgia Elizarraras William Leung Jasmyn S. Rabbanian (Parker) Joanna E. Elliot Yu B. Lin Mohammad R. Rahman Christina Y. Eng Stephen J. Liu Danikka Geelan Rioflorido Tiffany Farshi Alec Jansen C. Madriaga Marissa E. Ross Kalianny Flores David A. Mager Sahar Sayani Joshua J Gainey Kimberly A. Marlow Razan M. Sayegh Odette Jane M. Galvez Adva Marzini Rabanepur Cody J. Schuster Roshan J. George Rebecca J. McConnell Arti Sharma Fatima O. Gonzales Daphne T. Mercado Niloofar Sheikhan Ginina N. Goods John P. Meyer Lawrence M. Sherf Chad N. Gubler Evelina Z. Minosyan Arnitta Singh Angelica M Ha Norayr Z. Minosyan Paayal Singh Sadia Haleem Obiageli L. Momodu Vanessa M. Sok

Please join us in congratulating

our new Pharm. D.

Graduates from Roseman

University. We wish you all the best in your new

profession.

-NVSHP Board

2

In This Issue:

1 Congratulations 2 Chapter News 3 CE Events 4 NVSHP Annual 5 Board of Directors 6 Legislative Update 7-8 Pharmacy Practice in Specialty Areas 9-10 Recent Residency Research Projects 11-12 Welcome to the New Residents 13-14 Student Chapter News 15 Novel Drug Approvals

Editors:

Vanessa Vaupel, Pharm.D., BCPS

Cherelle Nelson,

Pharm.D. c/o 2020

Valerie Buckley

Pharm.D. c/o 2021

Call for Nominations for the following positions:

❖ Secretary ❖ Director-At-Large for Public Relations ❖ President-Elect

❖ To nominate a pharmacist for any of the above board positions, please click

Board Nominations. Deadline for applications is July 31st, 2019

Call for Nominations for Pharmacist of the Year in NV and Bowl of Hygeia award recipient:

❖ To nominate a pharmacist for Pharmacist of the Year and/or for the Bowl of Hygeia, please click Nominations . Deadline for nominations is July 31st, 2019.

Student Symposium:

❖ The Student Symposium is being held on November 2-3. The theme, “Be a Unicorn” will be fun and informative. Save the date!

❖ With ASHP midyear conference 2019 being held in Las Vegas this year, NVSHP wants to help you stand out in the crowd and make YOU the one these residency programs want!

❖ Come with a CV and we will give you advice on how to make your CV

unique!

❖ Stay tuned for more information and let your NVSHP student representatives know you want to be a UNICORN.

Chapter News

3

NVSHP Annual 2019

Registration is now OPEN. Sign up today!

NVSHP Annual Meeting

2019 Registration

4

CE Events

RSVP for this Law CE: Northern Nevada CE

RSVP for this Law CE:

Southern Nevada CE

September 17th, 2019

5

Board of Directors

Board of Directors

Della Bahmandar, Pharm.D., president@nvshp.org

Janice Taylor, Pharm.D., BCPS President Elect

Ragini Bhakta, Pharm.D., BCPS Immediate Past President

Vasudha Gupta, Pharm.D., BCACP, CDE Secretary secretary@nvshp.org

Sara Schroedl, Pharm.D., BCPP Treasurer treasurer@nvshp.org Stefanie Gann, Pharm.D., BCPS Director-at-Large Education North Alana Whittaker, Pharm.D., BCPS Director-at-Large Education South Adam Porath, Pharm.D., BCPS, BCACP Director-at-Large Legislation

Vanessa Vaupel, Pharm.D., BCPS Director of Public Relations Sami Busey, CPhT Pharmacy Technician Representative Cherelle Nelson PharmD Candidate c/o 2020 Student Representative Valerie Buckley PharmD Candidate c/o 2021

Student Representative

Membership Discounts

MIDTOWN SPANISH SPRINGS WEST RENO SOUTH RENO CARSON

820 South Virginia Street 4854 Sparks Blvd, #102 6160 Mae Anne Ave., #1 75 E. Patriot Blvd, #6 3633 Research Way, #104

Reno, NV 89502 Sparks, NV 89436 Reno, NV 89523 Reno, NV 89511 Carson City, NV 89706

775-375-5242 775-375-5242 775-375-5242 775-200-8840 775-841-4962

6

Legislative Update

The Nevada Legislature’s 80th session is in full swing this Spring. The Session concluded on June 3rd, 2019. The most significant pharmacist related legislation this year is the Senate Bill 361: Provides for the dispensing of self-administered hormonal contraceptives to any patient. This bill would allow Nevada pharmacists to prescribe self-administered contraception. To date, there has not been any “on the record” opposition to this bill. SB 361 is considered exempt which means it is not subject to any of the bill passage deadlines prior to the end of the Session NVSHP will continue to monitor this bill and provide testimony as necessary. Provider Status legislation has not yet been reintroduced into Congress. There are many bills related to drug shortages, drug pricing, and the opioid epidemic working their way through the legislative process. Representatives from ASHP has been providing testimony on these important issues to health system pharmacists.

Upcoming Nevada Board of Pharmacy Meetings

Reno September 4-5th &

December 4-5th Hyatt Place

1790 E Plumb Lane Reno, NV 89502 All meetings begin at 9:00 a.m.

Las Vegas October 9-10th

Hilton Garden Inn Las Vegas Strip South

7830 S. Las Vegas Boulevard Las Vegas NV 89123

All meetings begin at 9:00 a.m.

Adam Porath

Pharm.D., BCACP, BCPS-

AQ Cardiology

NVSHP Director-

at-Large, Legislation

7

Pharmacy Practice in Specialty Areas

At the Veterans Affairs Sierra Nevada Health Care System (VASNHCS),

clinical pharmacy specialists (CPS) are well integrated within the mental health care team. There are 4 mental health (MH) CPS at VASNHCS, providing services to inpatient psychiatry, mental health care in the primary care setting, substance use, and outpatient psychiatry. Pharmacists work alongside psychiatrists, social workers, psychologists, and other support staff to improve access to mental health care.

As a psychiatric pharmacist, major focus is placed on increasing access to care. As a nation, we are dealing with a shortage of MH professionals, including psychiatrists, which is only expected to worsen. In the outpatient setting, where I spend much of my time, patients are seen in clinic or via telehealth modalities to follow up on medications that were recently started, adverse effects, response to medication, and medication monitoring. These follow-ups allow for close monitoring of patients with MH disease states, and bridge gaps in care (e.g. a patient cannot be seen by a psychiatrist for 2 to 3 months due to availability). In the inpatient setting, the MH CPS provides transitions of care services including medication reconciliation upon admit and discharge, consultative service during admission, medication education to patients, and discharge follow-up. As a CPS in the VA system, MH CPS operate under a scope of practice that allows the prescribing of psychotropic medications for MH disease states. Once a patient has a diagnosis from a diagnosing provider (MD, PhD, SW), a MH CPS may provide medications and monitoring for that disease state per the scope of practice agreement. Our scope of practice is unique to the practice setting in mental health and requires completion of competencies and trainings related to the practice area.

I find satisfaction in providing care to patients from a pharmacist’s perspective. As the medication expert, we are uniquely qualified to identify medication related problems and provide solutions. I find the most meaningful interventions I have made are helping patients truly understand the purpose of their medication, and individualizing treatment based on each patients’ unique needs.

Sara M. Schroedl

Pharm.D., BCPP

VA Sierra Nevada

Health Care System-

Clinical Pharmacy Specialist, Mental

Health

8

Jumping from Rheumatoid Arthritis to Multiple Sclerosis to Idiopathic Pulmonary Fibrosis, the day in the life of a Specialty Pharmacist at the VA Sierra NV Healthcare system is never dull. These are just a few of the many conditions for which we must have a strong understanding of so that we can appropriately make recommendations for the medications used to treat these conditions. My name is Amy Ferguson, PharmD, BCACP, CDE, and I am one of the two specialty pharmacists at the Reno VA. I began with the initial expansion of the specialty services over 10 years ago when our role was strictly as part of a multidisciplinary diabetes clinic. From there we began to take on the medication monitoring of therapies involved with management of rheumatological conditions and over the years I have continued to expand our clinical role into a multitude of other disease states; this led to the need of a second specialty pharmacist position in 2016. I am proud to say that I have been able to build relationships with our Specialists over the years, some more difficult than others, and in many ways been able to demonstrate what clinical pharmacists are capable of while gaining the respect of these clinicians. I feel it has only improved the overall care that our patients receive in these areas.

As clinical services have expanded, we are now in a unique role in that we work with providers of several specialties including Rheumatology, Endocrine, Neurology, Pulmonary, Nephrology, and Cardiology to name a few. We don’t have the luxury to be able to concentrate on only one specialty in effort to know all of the intricate details, rather we must have a broader, more general understanding for management of many of these conditions. We must have a familiarity with any of the disease states that may pass through our area, or we need to be proficient in quickly familiarizing ourselves with such conditions. We ultimately manage the often high cost and/or high risk therapies that are utilized in these various settings. Our role in management of these conditions frequently varies and may be anything from formulary management to safety monitoring to care coordination to follow up of efficacy of therapies; sometimes it may be all of these roles when working with our patients. In addition to assisting with management of these medications, we must have a strong clinical practice for ambulatory care management, including routine disease states; HTN, DM, and Dyslipidemia, as these conditions often go hand in hand with management of specialty conditions. As we have a scope of practice within the VA, including a collaborative practice agreement in some of these areas, we are able to follow up and ensure therapies are maximized appropriately. This frees up the Specialist’s time and still enables the patients to be managed more frequently as needed. We precept PGY1 and PGY2 residents on our Specialty rotation with the only prerequisite being that the resident must have an ambulatory care rotation prior. As mentioned, there needs to be a strong knowledge base of ambulatory care as the conditions we are managing will only build from there. During my time as a pharmacy student and resident, I was lucky enough to have outstanding preceptors and role models who helped shape me into the clinician that I am now. I try to do the same for other pharmacy practitioners that are new to the practice. The nice thing is as our role changes frequently and as it requires us to be able to go from such a wide range of conditions, I learn new things every single day. This continues to be the case especially with the disease management focus going to biologic therapy and the ongoing approval of novel targeted therapies. With the need to consistently keep up with knowing about these medications and ways to manage these patients, our role is highly complex in nature, but also very rewarding at the end of the day.

Pharmacy Practice in Specialty Areas

Amy Ferguson

Pharm.D., BCACP, CDE

Clinical

Pharmacy Specialist, Specialty Practice

9

My name is Clayton Hamilton and I am currently a resident pharmacist completing my postgraduate year 2 (PGY2) in Pharmacy Outcomes and Health Care Analytics within the Veterans Health Administration (VHA). My journey with VHA began during my PGY1 experience where I served our nation’s Veterans in a small ambulatory clinic in Fort Harrison, MT. During my time there, I recognized that some patients did not receive the care they deserved, due in part to a lack of early identification of each patient’s healthcare needs. As I proceeded through the PGY1 program, I was exposed to VHA’s national anticoagulation patient dashboard, an interactive electronic tool that allows healthcare providers to identify high-risk patients and perform targeted interventions. These experiences ignited my passion to wield big data as a tool to improve patient care by providing healthcare providers with the means necessary to succeed in their clinical practice.

Currently, my PGY2 is based at the Veterans Integrated Service Network

(VISN) 21 Pharmacy Benefits Management (PBM) office in Reno, Nevada. Our network services Northern California, Hawaii, Nevada, and Manila. The PBM office employs various pharmacist program and data managers and is led by Scott Mambourg, the VISN Pharmacy Executive (VPE). Together, our team works tirelessly to improve Veteran care in a spirit of collaboration and ingenuity. Team mentorship and hands-on training developed my skillsets to identify actionable patients through data-driven clinical dashboards. My residency provides experiences in pharmacoeconomics, service and policy development, population health, database management, and formulary management. Equally important was realizing the value of earning provider buy-in to increase dashboard utilization. Ultimately, a new tool is only valuable if its end-users view the tool as necessary and incorporate it into patient care. To accomplish this, the PBM office has established task forces of healthcare providers and subject matter experts from each of the sites within VISN 21. These task forces routinely meet to share strong practices, review gaps, and discuss new metrics focused on improving patient care.

Throughout the year I worked on a case-control analysis of the rate of patient

progression to type 2 diabetes mellitus within the first year of initiating an atypical antipsychotic. The cohort consists of previously non-diabetic and antipsychotic-naive patients and includes data captured over the last 10 years. I also identified how many patients received guideline recommended metabolic monitoring during their first year of treatment with an atypical antipsychotic. The results will be presented to VISN 21’s mental health task force which will discuss this information and determine necessary next steps to improve patient care.

My PGY2 experience has highlighted a unique pharmacist role. Pharmacists

with data management skills can bridge the gap between clinical knowledge and data science by providing tools for population management, pharmacoeconomics, research, and more. I anticipate that future pharmacist data managers will expand into the realm of predictive analytics to tailor therapy to maximize benefit and avoid negative outcomes. After program completion, my goal is to help drive innovation in this area.

Recent Resident Research Projects

Clayton Hamilton

Pharm.D.

Veterans Health

Administration-

PGY-2 in

Pharmacy

Outcomes and

Health Care

Analytics

10

I am a PGY2 completing a Pharmacy Outcomes and Health Care Analytics residency at the Veterans Integrated Service Network (VISN 21) in Reno, Nevada. My residency project is a retrospective, quality improvement project assessing outcomes for Veterans with metastatic non-small cell lung cancer (NSCLC) who have been treated with atezolizumab, nivolumab, or pembrolizumab after failing first-line platinum-based chemotherapy.

Lung cancer includes both NSCLC and small cell lung cancer (SCLC); NSCLC

comprises 80-85% of cases and includes squamous cell, large cell, and adenocarcinoma subtypes. The three medications evaluated within the project are PDL-1/PD-1 immune-checkpoint inhibitors that work by blocking the mechanism by which cancer evades the immune system.

A retrospective review of these medications may better inform future clinical

decisions. Patients with unidentified morphology are included within the total cohort while those with known SCLC are excluded. The survival analysis of this VISN 21 project included 41 patients. Of those, the median overall survival (mOS) was 16, 8, and 7 months for atezolizumab (n = 9), nivolumab (n = 27), and pembrolizumab (n = 5), respectively. A subgroup with confirmed NSCLC morphology (n = 31) demonstrated a mOS of 7, 7, and 4 months for atezolizumab (n = 8), nivolumab (n = 19), and pembrolizumab (n = 4). The average number of infusions received prior to discontinuation or death were 14 for atezolizumab (range: 1-44), 11 for nivolumab (range: 1-39), and 6 for pembrolizumab (range: 3-10). Two of five patients treated with pembrolizumab were noted upon chart review to have discontinued due to suspected drug-induced pneumonitis. Additionally, this project identified a serious concern that over one-third of the patients included within the analysis (14 out of 41) received fewer than three doses before death or discontinuation. Further analysis is planned to identify patient-specific characteristics that may predict intolerance or non-response to these medications.

This VISN 21 evaluation observed that, for those with confirmed NSCLC, the

mOS of each immunotherapy was observed to be shorter than in clinical trials. For the total cohort, atezolizumab demonstrated longer mOS. Current findings are significantly limited by small numbers of patients meeting inclusion. Information collected on doses received and reasons for discontinuation suggests that pembrolizumab may be less well-tolerated with increased incidence of documented drug-induced pneumonitis.

The project aims to better inform prescribing practices by discouraging use within subgroups of patients who are unlikely to respond and in which the medication may only reduce quality of life in the setting of poor outcomes.

Throughout this project, I leveraged data analytics skills learned during

residency including the use of structured query language (SQL) data queries to efficiently search the VA Clinical Data Warehouse (CDW). The CDW is an extensive database containing electronic health record data dating back to 1999. I have gained an appreciation of data analytics as a powerful way to better healthcare quality. I have submitted an abstract of the current residency project for poster presentation at ASHP’s Summer Meeting in June 2019 and look forward to completing additional analysis in preparation for a future manuscript.

Recent Resident Research Projects

Kjersti Rich

Pharm.D.

Veterans Integrated Service Network-

PGY-2 in Pharmacy

Outcomes and Health Care

Analytics

11

VA-Veterans Integrated Services Networks (VISN-21) PGY-2 Residents: ❖ Brandy Gore, Pharm.D.

-Pacific University, College of Pharmacy ❖ Erica Howard, Pharm.D.

-Howard University, College of Pharmacy

VA Sierra Nevada PGY-2 Residents: ❖ Chanese Hampton, Pharm.D.

-Psychiatry PGY-2 Resident ❖ Megan Ooms, Pharm.D.

-Geriatric PGY-2 Resident -Western New England University, College of Pharmacy

VA Sierra Nevada PGY-1 Residents:

❖ Keilana Fisher, Pharm.D. -University of Washington, College of Pharmacy

❖ Steve Flynn, Pharm.D. -Idaho State University, College of Pharmacy

❖ Aaron Kim, Pharm.D. -Roseman University of Health Sciences, College of Pharmacy

❖ Nhien Nguyen, Pharm.D. -Oregon State University, College of Pharmacy

❖ Craig Ratliff, Pharm.D. -Campbell University, College of Pharmacy

❖ Elyssa Valencerina, Pharm.D. -Touro University, California, College of Pharmacy

and

VA Sierra Nevada

PGY-1&2

VA- Veterans Integrated Services Networks (VISN 21)

PGY-2

Welcome to the New Residents of 2019-2020

12

PGY-1 Residents:

❖ Ross Garrett, Pharm.D. -University of New England, College of Pharmacy

❖ Jennifer Hipskind, Pharm.D. -Ohio Northern University, Raabe, College of Pharmacy

❖ Parker Webster, Pharm.D. -Idaho State University, College of Pharmacy

PGY-2 Critical Care Resident:

❖ Michelle Chantley, Pharm.D. -University of California, San Francisco, School of Pharmacy -PGY-1: Saint Alphonsus Regional Medical Center- Boise, ID

PGY-2 Infectious Disease Residents: ❖ Marshall Renna, Pharm.D.

-University of Montana, Skaggs, School of Pharmacy -PGY-1: Southern Arizona VA Healthcare System- Tucson, AZ

❖ Esther Yu, Pharm.D. -University of California, San Francisco, School of Pharmacy -PGY-1: Renown Reginal Medical Center- Reno, NV

PGY-2 Emergency Medicine Resident:

❖ Lauren Milner, Pharm.D. -Texas Tech University of Health Sciences Center, School of Pharmacy -PGY-1: Providence St. Peter Hospital- Olympia, WA

PGY-2 Ambulatory Care Resident:

❖ Janeen Ibarreta, Pharm.D. -Roseman University of Health Sciences, College of Pharmacy -PGY-1: Renown Regional Medical Center- Reno, NV

Welcome to the incoming 2019-2020

Residents of the Las

Vegas Valley

Welcome to the New Residents of 2019-2020

13

Jacqueline Lee

Pharm.D. Candidate

2020 Roseman University College of Pharmacy

Student Alliance President 2018-2019

Student Chapter News

From Vegas to Carson City and Back:

During the 80th Session of the Nevada Legislature, a group of students made the trip up to the capitol to provide health screenings for legislators, and I had the great opportunity to be one of these students. The free screenings we provided were no different from any other health fair, we offered to measure blood pressure, blood glucose and cholesterol levels. Perhaps the only difference was, we just happened to meet with and engage in conversation with several of our Senators, and flying was our primary mode of transportation. As we performed our services, we also the chance to advocate for the profession of pharmacy. From speaking th several legislators and their staff, it was satisfying to learn that the public is beginning to realize how invaluable pharmacists are. The number of services that pharmacists can provide continues to grow, thus the nationwide campaign for provider status. Knowing this, we as students could show how helpful pharmacists can be, even if we were only providing words of reassurance that their numbers were within the normal limits.

Along with advocating for our profession, we promoted our school Roseman

University, encouraging Senators to come and visit us the next time they were in town. The College of Pharmacy at Roseman is the only pharmacy program in our state, so there is a lot of room for growth. With the State’s support, our program could reach so many more communities outside of Clark County.

Although the tasks we performed were not much different, if at all, from a typical health fair, this visit to the capitol held a lot of significance for the school and the profession. And while we started the day with a 6 am flight, the experience and opportunity were well worth the early morning wakeup.

14

Student Chapter News

Policy Can Be Fun

The student chapter of NVSHP is very active in making the student pharmacists, pharmacists, and patients more knowledgeable about our profession. We want to educate our colleagues of the importance of Provider Status for our profession of Pharmacy and how we can show our patients that we are providers in healthcare. To achieve this, we provided fun and educational events for participants to actively learn about pharmacy.

In October we were successful in getting Governor Sandoval to declare

October as Pharmacist Appreciation Month. We celebrated by providing donuts to our colleagues for learning about fun facts about pharmacy by participating in our “Take a Bite out of Policy” Event. Some of these facts included pharmacy history (“Did you know that Benjamin Franklin was a pharmacist?”), drug names (“Did you know cilastatin is not for cholesterol?”), and legislature updates (“Did you know that pharmacists in Nevada will be able to prescribe and dispense birth control?”).

In February we participated in a Practice Advancement Initiative (PAI) project

with ASHP in which many of our pharmacy students and local pharmacists volunteered to tell their stories as to why they were healthcare providers, how they are actively advocating and the importance of advocating for our profession of Pharmacy. Every day of PAI week, these stories were featured along with facts about the Practice Advancement Initiative and how we, as pharmacists and student pharmacists, make a significant impact in our communities the services we provide (immunizations, medical therapy management [MTM], comprehensive medical reviews [CMRs], and more). The feedback from the community was amazing. Many did not realize that these services are there for our patients in their local community pharmacies and that most of these services were covered by their insurance. Nor did they realize we are readily accessible to answer medication and non-emergency medical questions. It was an eye-opening experience for many of us about how much our community knows about our profession.

Lastly throughout the school year, our members hold “Policy on Tap” events where they mediate discussions on controversial pharmacy topics between our colleagues at a local bar. Some of the topics discussed during these events: drug/IV bag shortages, medical marijuana legislature, male birth control studies, pharmacists being granted to prescribe and dispense birth control, the current opioid crisis, the pros and cons of Kratom being a scheduled drug, and many more. This event is always in demand due to the great discussions that result from initiating these types of topics and the lack of these topics in our studies.

Through all these events, we were able to educate our community, our patients, our pharmacists, and our student pharmacists on the importance of being current on pharmacy legislature and being involved in advocating for our profession all while having fun in the process.

Cherelle Nelson

Pharm.D. Candidate 2020

Roseman University College of Pharmacy

NVSHP Student Representative 2018-

2020, Student Alliance VP of Policy

2018-2019

15

Brand Name Generic Name Date Approved Indication

Jeuveau prabotulinumtoxinA-xvfs-xvfs 2/1/2019 For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients

Cablivi caplacizumab-yhdp 2/6/2019 To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP)

Egaten Spravato

triclabendazole esketamine

2/13/2019 3/06/2019

To treat fascioliasis, a parasitic infection caused

by two species of flatworms or trematodes that

mainly affect the liver, sometimes referred to as

“liver flukes”

To treat treatment-resistant depression

Zulresso Brexanolone 3/19/2019 To treat postpartum depression (PPD) in adult women

Sunosi solriamfetol

3/20/2019

To treat excessive sleepiness in adult patients with

narcolepsy or obstructive sleep apnea

Mayzent siponimod 3/26/2019 To treat adults with relapsing forms of multiple sclerosis

Evenity romosozumab-aqqg 4/9/2019 To treat osteoporosis in postmenopausal women

at high risk of fracture

Balversa erdafitinib

4/12/2019 To treat adult patients with locally advanced or

metastatic bladder cancer

Skyrizi risankizumab-rzaa 4/23/2019 To treat moderate-to-severe plaque psorisasis in adults who are candidates for systemic therapy or phototherapy

Vyndaqul tafamidis meglumine 5/03/2019 To treat heart disease (cardiomyopathy) caused

by transthyretin mediated amyloidosis (ATTR-

CM) in adults

Piqray alpelisib 5/24/2019 To treat breast cancer

Polivy polatuzumab vedotin-piiq 6/10/2019 To treat adult patients with relapsed or refractory

diffuse large B-cell lymphoma

Vylessi bremelanotide 6/21/2019 To treat hypoactive sexual desire disorder in premenopausal women

Xpovio selinexor 7/03/2019 To treat adult patients with relapsed or refractory multiple myeloma (RRMM)

For More Information and Drug Trials, please visit the FDA HERE

Become involved with NVSHP!

NVSHP is seeking members who would like to actively

participate in changing the profession of pharmacy. We would love to have you serve on one of our standing

committees: Education, Membership, or Legislation. If you are interested in becoming more

involved, please email us at: nvshp@nvshp.org.